Status: Recruiting
Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))
The aim of this study is to assess the effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis)).
Participants needed: 120
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: BiocodexUpdated: Aug 27, 2025Locations: 1
Eligibility criteria
Adult Patients, ≥18 years old. [+7]
History of hypersensitivity to the study treatments (active substance or excipie... [+19]